Rapid Review Quiz: Hospital-Acquired Pneumonia

September 15, 2022

According to the CDC 2022 Special Report: COVID-19 – U.S. Impact on Antimicrobial Resistance, hospital-acquired infections and deaths among seven pathogens increased at least 15% from 2019 to 2020, with some pathogens increasing more than others, and a few decreasing. Carbapenem-resistant Acinetobacter had a 78% increase, whereas vancomycin-resistant Enterococcus and methicillin-resistant S aureus increased 14% and 13%, respectively. Hospital-acquired infections caused by drug-resistant M tuberculosis dropped.

Learn more about Acinetobacter.


Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.